Outcome of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Patients With Intermediate SYNTAX II Score.


Journal

Current problems in cardiology
ISSN: 1535-6280
Titre abrégé: Curr Probl Cardiol
Pays: Netherlands
ID NLM: 7701802

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 11 11 2022
accepted: 11 11 2022
pubmed: 20 11 2022
medline: 4 1 2023
entrez: 19 11 2022
Statut: ppublish

Résumé

Patients with intermediate SYNTAX II score have been representing a confusion in our daily practice for interventional cardiologists whether to treat them by percutaneous coronary intervention (PCI) using second generation drug eluting stents or by coronary artery bypass grafting (CABG). We enrolled 214 consecutive patients with intermediate SYNTAX II score to undergo revascularization (109 patients underwent PCI and 105 patients underwent CABG) after Heart Team discussion. We compared both procedures with respect to the primary composite end point of major adverse cardiac or cerebrovascular events (all-cause mortality, myocardial infarction, target vessel revascularization or stroke) at 40 months post procedure. At 40 months post revascularization procedure, the primary end-point occurred in 22 patients and 15 patients in the PCI and CABG groups, respectively (hazard ratio, 1.65; 95% confidence interval, 0.87-3.14; P = 0.13). No significant differences were detected between both groups regarding the composite incidence of all-cause mortality, myocardial infarction, target vessel revascularization, and stroke. CABG significantly provided better quality of life than PCI for patients with intermediate SYNTAX II score. In patients with intermediate SYNTAX II score, there was no statistically significant difference between the PCI using second generation drug eluting stents and CABG with respect to the incidence of MACCE at 40 months post revascularization procedure.

Identifiants

pubmed: 36402217
pii: S0146-2806(22)00409-1
doi: 10.1016/j.cpcardiol.2022.101512
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101512

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Waleed Etman (W)

Medical Research Institute, Alexandria University, Alexandria, Egypt. Electronic address: etman.waleed@hotmail.com.

Mohamed Loutfi (M)

Faculty of Medicine, Alexandria University, Alexandria, Egypt.

Kamal Ahmed (K)

Medical Research Institute, Alexandria University, Alexandria, Egypt.

Salah Eltahan (S)

Faculty of Medicine, Alexandria University, Alexandria, Egypt.

Amr Rayan (A)

Faculty of Medicine, Alexandria University, Alexandria, Egypt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH